219 related articles for article (PubMed ID: 21224347)
1. Phospholipase D meets Wnt signaling: a new target for cancer therapy.
Kang DW; Choi KY; Min do S
Cancer Res; 2011 Jan; 71(2):293-7. PubMed ID: 21224347
[TBL] [Abstract][Full Text] [Related]
2. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
3. Wnt signaling and cancer development: therapeutic implication.
Paul S; Dey A
Neoplasma; 2008; 55(3):165-76. PubMed ID: 18348648
[TBL] [Abstract][Full Text] [Related]
4. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.
Feng Y; Bommer GT; Zhai Y; Akyol A; Hinoi T; Winer I; Lin HV; Cadigan KM; Cho KR; Fearon ER
Cancer Res; 2007 Jan; 67(2):482-91. PubMed ID: 17234755
[TBL] [Abstract][Full Text] [Related]
5. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
6. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
Kang DW; Min do S
PLoS One; 2010 Aug; 5(8):e12109. PubMed ID: 20711340
[TBL] [Abstract][Full Text] [Related]
7. An oncogenic hub: beta-catenin as a molecular target for cancer therapeutics.
Takemaru KI; Ohmitsu M; Li FQ
Handb Exp Pharmacol; 2008; (186):261-84. PubMed ID: 18491056
[TBL] [Abstract][Full Text] [Related]
8. Targeting the WNT/beta-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options.
Gehrke I; Gandhirajan RK; Kreuzer KA
Eur J Cancer; 2009 Nov; 45(16):2759-67. PubMed ID: 19729298
[TBL] [Abstract][Full Text] [Related]
9. New avenues to target Wnt/β-catenin signaling.
Verkaar F; Zaman GJ
Drug Discov Today; 2011 Jan; 16(1-2):35-41. PubMed ID: 21111060
[TBL] [Abstract][Full Text] [Related]
10. Wnt/beta-catenin signaling in cancer stemness and malignant behavior.
Fodde R; Brabletz T
Curr Opin Cell Biol; 2007 Apr; 19(2):150-8. PubMed ID: 17306971
[TBL] [Abstract][Full Text] [Related]
11. The Wnt/beta-catenin pathway in adrenocortical development and cancer.
El Wakil A; Lalli E
Mol Cell Endocrinol; 2011 Jan; 332(1-2):32-7. PubMed ID: 21094679
[TBL] [Abstract][Full Text] [Related]
12. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells.
Lee HS; Park MH; Yang SJ; Park KC; Kim NS; Kim YS; Kim DI; Yoo HS; Choi EJ; Yeom YI
Life Sci; 2007 Jan; 80(7):690-8. PubMed ID: 17157329
[TBL] [Abstract][Full Text] [Related]
13. Targeting Wnt signaling in colon cancer stem cells.
de Sousa EM; Vermeulen L; Richel D; Medema JP
Clin Cancer Res; 2011 Feb; 17(4):647-53. PubMed ID: 21159886
[TBL] [Abstract][Full Text] [Related]
14. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
[TBL] [Abstract][Full Text] [Related]
15. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
[TBL] [Abstract][Full Text] [Related]
16. A WNTer wonderland in Snowbird.
He X; Axelrod JD
Development; 2006 Jul; 133(14):2597-603. PubMed ID: 16794030
[TBL] [Abstract][Full Text] [Related]
17. Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin.
Jin T; George Fantus I; Sun J
Cell Signal; 2008 Oct; 20(10):1697-704. PubMed ID: 18555664
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
[TBL] [Abstract][Full Text] [Related]
19. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
20. Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis.
Lai SL; Chien AJ; Moon RT
Cell Res; 2009 May; 19(5):532-45. PubMed ID: 19365405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]